RD
Robert Driscoll Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
20
Avg Return
Past Year
Past Year
20%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
80%
Neutral
20%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $38 |
217%
upside
| 3 | +18% |
0
%
| 14 Nov ‘25 19 days ago |
|
|
|
Outperform
Maintained
| $80 |
3%
upside
| 5 | +12% |
0
%
| 6 Nov ‘25 27 days ago |
|
|
|
Outperform
Maintained
| $38 |
256%
upside
| 1 | -45% |
0
%
| 20 Oct ‘25 1 month ago |
|
|
|
Outperform
Upgraded
| $18 |
74%
upside
| 2 | +129% |
0
%
| 20 Oct ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $27 |
101%
upside
| 1 | +3.5% |
0
%
| 14 Jul ‘25 4 months ago |
|
|
|
Neutral
Reiterated
| $4 |
190%
upside
| 2 | – |
–
| 15 May ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $6 |
554%
upside
| 2 | -13% |
0
%
| 9 May ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $17 |
1%
upside
| 1 | +139% |
0
%
| 21 Mar ‘25 8 months ago |
|
|
|
Neutral
Downgraded
| $12 |
5%
downside
| 1 | – |
–
| 12 Mar ‘25 8 months ago |
|
|
|
Outperform
Reiterated
| $32 |
285%
upside
| 1 | -30% |
0
%
| 26 Feb ‘25 9 months ago |
|
|
|
Outperform
Reiterated
| $52 |
51%
upside
| 1 | +32% |
0
%
| 17 Dec ‘24 11 months ago |
|